Use of a novel access technology for femoral artery catheterization: results of the RECITAL trial.

Objective: To present results of a registry of a novel vascular access device.

Background: Arterial access has been largely unchanged for 60 years. The Arstasis device creates a novel shallow-angle arterial access designed to facilitate hemostasis without use of a vascular closure device (VCD) or implantation of a foreign body for closure.